谷歌浏览器插件
订阅小程序
在清言上使用

Sex and Survival Outcomes in Patients with Renal Cell Carcinoma Receiving First-Line Immune-Based Combinations.

CANCER IMMUNOLOGY IMMUNOTHERAPY(2024)

引用 0|浏览41
暂无评分
关键词
ARON-1 study,Gender differences,Immunotherapy,Immune-based combinations,NCT05287464,Renal cell carcinoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要